- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04771221
Method of Early Diagnosis of Laryngopharyngeal Reflux (LPR)
Method of Early Diagnosis of Laryngopharyngeal Reflux in an Outpatient Appointment of an Otorhinolaryngologist
The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire.
Clinical survey, medical history. 2. Objective methods for assessing the patient's condition:
- examination of ENT organs. 3. Laboratory and instrumental research methods: Endoscopic laryngoscopy and video laryngoscopy, pH-metry, acoustic voice analysis.
4.Sociological method. 5. Subjective methods for assessing the condition of the larynx. 6. Аnalysis of the received data
Study Overview
Status
Detailed Description
The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire.
Clinical survey, medical history 2. Objective methods for assessing the patient's condition:
- examination of ENT organs: rhinoscopy, otoscopy, pharyngoscopy and laryngoscopy 3. Laboratory and instrumental research methods - Endoscopic laryngoscopy and video laryngoscopy. pH-metry: The collection of mucus from the laryngopharynx for the determination of acid-base values. Acoustic voice analysis: objective assessment of the voice condition 4.Sociological method: determination of lifestyle, nutrition, the presence or absence of bad habits.
5. Subjective methods for assessing the condition of the larynx - Questionnaires.
6. Аnalysis of the received data
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Almaty, Kazakhstan
- SOS Medical Assistance
-
Almaty, Kazakhstan
- V-ent
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient's informed consent
- Age: 18-75 years old
- No serious somatic diseases.
- Patients with complaints of sore throat, coughing, burning sensation in the throat, coughing, frequent sore throat, difficulty swallowing, lump in the throat, foreign body feeling in the throat, voice changes, heartburn and belching.
- Diagnosis: Chronic pharyngitis
- Chronic laryngitis
Exclusion Criteria:
- Disagreement to participate in scientific research
- Age: under 18 and over 76
- Severe somatic diseases, organic lesions of the gastrointestinal tract and ENT organs
- Patients with pulmonary pathologies
- Patients with allergic manifestations (seasonal hay fever, asthma, etc.)
- With diagnoses: Acute respiratory diseases
- Patients with general neuralgic disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Main group
Patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching.
|
The collection of mucus from the laryngopharynx to determine the acid-base values through pH-metry.
Completion of the questionnaire index of reflux symptoms.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
Evaluation results range from 0 to 5, where 0 is an indicator of no problem, and 5 is an indicator of a serious problem
Video laryngoscopy and assessment of the presence / severity of the symptoms.
Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem
acoustic analysis of the voice was performed in singers with voice disorders before and after treatment using program of the Lingwaves
|
Experimental: Control group 1
Patients with an early diagnosis of Gastroesophageal reflux disease
|
The collection of mucus from the laryngopharynx to determine the acid-base values through pH-metry.
Completion of the questionnaire index of reflux symptoms.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
Evaluation results range from 0 to 5, where 0 is an indicator of no problem, and 5 is an indicator of a serious problem
Video laryngoscopy and assessment of the presence / severity of the symptoms.
Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem
|
Experimental: Control group 2
Patients without complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching.
|
The collection of mucus from the laryngopharynx to determine the acid-base values through pH-metry.
Completion of the questionnaire index of reflux symptoms.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
Evaluation results range from 0 to 5, where 0 is an indicator of no problem, and 5 is an indicator of a serious problem
Video laryngoscopy and assessment of the presence / severity of the symptoms.
Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acidity level of the main group, Week 0
Time Frame: at the inclusion to the study
|
The acidity level of the larynx is assessed using litmus paper.
The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.
|
at the inclusion to the study
|
Acidity level of the control group 1, Week 0
Time Frame: at the inclusion to the study
|
The acidity level of the larynx is assessed using litmus paper.
The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.
|
at the inclusion to the study
|
Acidity level of the control group 2, Week 0
Time Frame: at the inclusion to the study
|
The acidity level of the larynx is assessed using litmus paper.
The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.
|
at the inclusion to the study
|
"Index of reflux symptoms" of the main group, Week 0
Time Frame: at the inclusion to the study
|
Patients will be asked to complete the Reflux Symptom Index questionnaire.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
The severity of the problem is calculated as the summation of all points.
The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.
|
at the inclusion to the study
|
"Index of reflux symptoms" of the control group 1, Week 0
Time Frame: at the inclusion to the study
|
Patients will be asked to complete the Reflux Symptom Index questionnaire.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
The severity of the problem is calculated as the summation of all points.
The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.
|
at the inclusion to the study
|
"Index of reflux symptoms" of the control group 2, Week 0
Time Frame: at the inclusion to the study
|
Patients will be asked to complete the Reflux Symptom Index questionnaire.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
The severity of the problem is calculated as the summation of all points.
The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.
|
at the inclusion to the study
|
Endoscopic laryngoscopy of the main group, Week 0
Time Frame: at the inclusion to the study
|
Assessment of the state of the larynx on the scale of reflux symptoms.
Where the presence and severity of the sign is assessed in points from 0 to 4.
Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.
|
at the inclusion to the study
|
Endoscopic laryngoscopy of the control group 1, Week 0
Time Frame: at the inclusion to the study
|
Assessment of the state of the larynx on the scale of reflux symptoms.
Where the presence and severity of the sign is assessed in points from 0 to 4.
Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.
|
at the inclusion to the study
|
Endoscopic laryngoscopy of the control group 2, Week 0
Time Frame: at the inclusion to the study
|
Assessment of the state of the larynx on the scale of reflux symptoms.
Where the presence and severity of the sign is assessed in points from 0 to 4.
Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.
|
at the inclusion to the study
|
Acoustic voice analysis of the main group, Week 0
Time Frame: at the inclusion to the study
|
Acoustic analysis of the voice was performed in patients with a voice profession who had a voice disorder using computer program of the Lingwaves.
|
at the inclusion to the study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acidity level of the main group, Week 4
Time Frame: at 4 weeks after initial treatment
|
The acidity level of the larynx is assessed using litmus paper.
The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.
|
at 4 weeks after initial treatment
|
Acidity level of the control group 1, Week 4
Time Frame: at 4 weeks after initial treatment
|
The acidity level of the larynx is assessed using litmus paper.
The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.
|
at 4 weeks after initial treatment
|
Acidity level of the control group 2, Week 4
Time Frame: at 4 weeks after initial treatment
|
The acidity level of the larynx is assessed using litmus paper.
The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.
|
at 4 weeks after initial treatment
|
"Index of reflux symptoms" of the main group, Week 4
Time Frame: at 4 weeks after initial treatment
|
Patients will be asked to complete the Reflux Symptom Index questionnaire.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
The severity of the problem is calculated as the summation of all points.
The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.
|
at 4 weeks after initial treatment
|
"Index of reflux symptoms" of the control group 1, Week 4
Time Frame: at 4 weeks after initial treatment
|
Patients will be asked to complete the Reflux Symptom Index questionnaire.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
The severity of the problem is calculated as the summation of all points.
The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.
|
at 4 weeks after initial treatment
|
"Index of reflux symptoms" of the control group 2, Week 4
Time Frame: at 4 weeks after initial treatment
|
Patients will be asked to complete the Reflux Symptom Index questionnaire.
An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out.
The severity of the problem is calculated as the summation of all points.
The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.
|
at 4 weeks after initial treatment
|
Endoscopic laryngoscopy of the main group, Week 4
Time Frame: at 4 weeks after initial treatment
|
Assessment of the state of the larynx on the scale of reflux symptoms.
Where the presence and severity of the sign is assessed in points from 0 to 4.
Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.
|
at 4 weeks after initial treatment
|
Endoscopic laryngoscopy of the control group 1, Week 4
Time Frame: at 4 weeks after initial treatment
|
Assessment of the state of the larynx on the scale of reflux symptoms.
Where the presence and severity of the sign is assessed in points from 0 to 4.
Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.
|
at 4 weeks after initial treatment
|
Endoscopic laryngoscopy of the control group 2, Week 4
Time Frame: at 4 weeks after initial treatment
|
Assessment of the state of the larynx on the scale of reflux symptoms.
Where the presence and severity of the sign is assessed in points from 0 to 4.
Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.
|
at 4 weeks after initial treatment
|
Acoustic voice analysis of the main group, Week 4
Time Frame: at 4 weeks after initial treatment
|
Acoustic analysis of the voice was performed in patients with a voice profession who had a voice disorder using computer program of the Lingwaves
|
at 4 weeks after initial treatment
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Gastrointestinal Diseases
- Otorhinolaryngologic Diseases
- Esophageal Motility Disorders
- Deglutition Disorders
- Esophageal Diseases
- Laryngeal Diseases
- Gastroesophageal Reflux
- Laryngopharyngeal Reflux
- Laryngitis
- Croup
Other Study ID Numbers
- 14-2020 (Other Identifier: KazMUCE)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastro Esophageal Reflux
-
Klinikum Garmisch-PatenkirchenNot yet recruitingReflux, Gastroesophageal | Gastro-esophageal RefluxGermany
-
Asian Institute of Gastroenterology, IndiaCompletedGastro Esophageal Reflux DiseaseIndia
-
Medtronic - MITGCompletedGastro Esophageal Reflux DiseaseIsrael
-
Vrije Universiteit BrusselCompletedGastro-esophageal RefluxBelgium
-
Mayo ClinicWithdrawnGastro-esophageal Reflux Disease (GERD)United States
-
Medtronic - MITGWithdrawnGastro Esophageal Reflux DiseaseIsrael
-
MAAB (Shanghai) Medical Device LimitedRD Biomed LtdCompletedGastro-esophageal Reflux DiseaseChina
-
Vrije Universiteit BrusselCompleted
-
Reckitt Benckiser Healthcare (UK) LimitedCompletedGastro-esophageal Reflux Disease (GERD)China
-
James J. Peters Veterans Affairs Medical CenterUnknownGastro Esophageal Reflux DisorderUnited States
Clinical Trials on pH metry
-
Assistance Publique - Hôpitaux de ParisCompleted
-
ElsanCompletedObstructive Sleep Apnea | Reflux, LaryngopharyngealFrance
-
Children's Hospital of PhiladelphiaWithdrawnLaryngopharyngeal RefluxUnited States
-
Medtronic - MITGCompletedGastro Esophageal Reflux DiseaseIsrael
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Mayo ClinicCompleted
-
University of AarhusCompleted
-
Mayo ClinicCompleted
-
Phio Pharmaceuticals Inc.RecruitingSquamous Cell Carcinoma of the Skin | Malignant Melanoma of Skin | Merkel Cell Carcinoma of SkinUnited States